422 related articles for article (PubMed ID: 30159340)
21. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
22. Lambda-cyhalothrin exposure alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in platelets and liver of rats.
Aouey B; Fares E; Chtourou Y; Bouchard M; Fetoui H
Chem Biol Interact; 2019 Sep; 311():108796. PubMed ID: 31421116
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of ectonucleotidases: relevance for the treatment of cardiovascular disorders.
Mathieu P
Eur J Pharmacol; 2012 Dec; 696(1-3):1-4. PubMed ID: 23000390
[TBL] [Abstract][Full Text] [Related]
24. Pathological roles of purinergic signaling in the liver.
Vaughn BP; Robson SC; Burnstock G
J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
[TBL] [Abstract][Full Text] [Related]
25. Tackling Chronic Pain and Inflammation through the Purinergic System.
Magni G; Riccio D; Ceruti S
Curr Med Chem; 2018; 25(32):3830-3865. PubMed ID: 28699505
[TBL] [Abstract][Full Text] [Related]
26. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC
Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736
[TBL] [Abstract][Full Text] [Related]
27. Purinergic Signaling in the Cardiovascular System.
Burnstock G
Circ Res; 2017 Jan; 120(1):207-228. PubMed ID: 28057794
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Nucleotides Regulate Arterial Calcification by Activating Both Independent and Dependent Purinergic Receptor Signaling Pathways.
Opdebeeck B; Orriss IR; Neven E; D'Haese PC; Verhulst A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076470
[TBL] [Abstract][Full Text] [Related]
29. Purinergic signaling in atherosclerosis.
Ferrari D; Vitiello L; Idzko M; la Sala A
Trends Mol Med; 2015 Mar; 21(3):184-92. PubMed ID: 25637413
[TBL] [Abstract][Full Text] [Related]
30. Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders.
Bonan CD
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):739-50. PubMed ID: 22963442
[TBL] [Abstract][Full Text] [Related]
31. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
Schetinger MR; Morsch VM; Bonan CD; Wyse AT
Biofactors; 2007; 31(2):77-98. PubMed ID: 18806312
[TBL] [Abstract][Full Text] [Related]
32. Role of purinergic receptors in the Alzheimer's disease.
Cieślak M; Wojtczak A
Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
[TBL] [Abstract][Full Text] [Related]
33. Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases.
Andrejew R; Glaser T; Oliveira-Giacomelli Á; Ribeiro D; Godoy M; Granato A; Ulrich H
Adv Exp Med Biol; 2019; 1201():275-353. PubMed ID: 31898792
[TBL] [Abstract][Full Text] [Related]
34. Profile of nucleotide catabolism and ectonucleotidase expression from the hippocampi of neonatal rats after caffeine exposure.
Da Silva RS; Richetti SK; Tonial EM; Bogo MR; Bonan CD
Neurochem Res; 2012 Jan; 37(1):23-30. PubMed ID: 21842269
[TBL] [Abstract][Full Text] [Related]
35. Purinergic Signaling in Glioma Progression.
Braganhol E; Wink MR; Lenz G; Battastini AMO
Adv Exp Med Biol; 2020; 1202():87-108. PubMed ID: 32034710
[TBL] [Abstract][Full Text] [Related]
36. Purinergic Signaling During Immune Cell Trafficking.
Ferrari D; McNamee EN; Idzko M; Gambari R; Eltzschig HK
Trends Immunol; 2016 Jun; 37(6):399-411. PubMed ID: 27142306
[TBL] [Abstract][Full Text] [Related]
37. Purinergic Signaling in the Hallmarks of Cancer.
Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
[TBL] [Abstract][Full Text] [Related]
38. Aeromonas caviae alters the activities of ecto-enzymes that hydrolyze adenine nucleotides in fish thrombocytes.
Baldissera MD; Souza CF; Verdi CM; Vizzotto BS; Santos RCV; Baldisserotto B
Microb Pathog; 2018 Feb; 115():64-67. PubMed ID: 29253595
[TBL] [Abstract][Full Text] [Related]
39. Zebrafish models: Gaining insight into purinergic signaling and neurological disorders.
Nabinger DD; Altenhofen S; Bonan CD
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109770. PubMed ID: 31678483
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.
Yegutkin GG
Biochim Biophys Acta; 2008 May; 1783(5):673-94. PubMed ID: 18302942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
